Download PDF
Planta Med 2024; 90(01): 47-62
DOI: 10.1055/a-2157-8913
Natural Product Chemistry and Analytical Studies
Reviews

Review: The Chemistry, Toxicity and Antibacterial Activity of Curcumin and Its Analogues

Hannah J. Denison
1   Syngenta, Jealottʼs Hill International Research Centre, Bracknell, Berkshire, UK
,
Sianne L. Schwikkard
2   Department of Chemical and Pharmaceutical Science, Kingston University, London, UK
,
Mouhamad Khoder
3   Department of Pharmacy, Kingston University, London, UK
,
Alison F. Kelly 
4   Department of Applied and Human Sciences, Kingston University, London, UK
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Antimicrobial resistance is a global challenge that is already exacting a heavy price both in terms of human health and financial cost. Novel ways of approaching this crisis include the investigation of natural products. Curcumin is the major constituent in turmeric, and it is commonly used in the preparation of Asian cuisine. In addition, it possesses a wide range of pharmacological properties. This review provides a detailed account of curcumin and its analoguesʼ antibacterial activity against both gram-positive and gram-negative isolates, including its potential mechanism(s) of action and the safety and toxicity in human and animal models. We also highlight the key challenges in terms of solubility/bioavailability associated with the use of curcumin and include research on how these challenges have been overcome.

Key words

Curcumin - Curcuma longa - Zingiberaceae - curcumin analogues - antibacterial - solubility - mechanism - toxicity


Publication History

Received: 18 April 2023

Accepted after revision: 19 August 2023

Accepted Manuscript online:
21 August 2023

Article published online:
28 September 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 World Health Organization. Antimicrobial resistance. 2021. Accessed December 05, 2021 at: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
    PubMedGoogle Scholar
  • 2 World Health Organization. Antibiotic resistance fact sheet. 2016. Accessed July 17, 2023 at: http://www.who.int/mediacentre/factsheets/antibiotic-resistance/en/
    PubMedGoogle Scholar
  • 3 Antimicrobial Resistance Collaborators. Global burden if bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022; 399: 629-655
    Google Scholar
  • 4 AMR Industry Declaration. Declaration by the pharmaceutical, biotechnology and diagnosis industries on combating antimicrobial resistance. 2016. Accessed March 17, 2023 at: https://www.amrindustryalliance.org/amr-industry-alliance-declaration/
    PubMedGoogle Scholar
  • 5 Boyd NK, Teng C, Frei CR. Brief overview of approaches and challenges in new antibiotic development: A focus on drug repurposing. Front Cell Infect Microbiol 2021; 11: 684515
    CrossrefPubMedGoogle Scholar
  • 6 Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Altern Complement Med 2003; 9: 161-168
    CrossrefPubMedGoogle Scholar
  • 7 Vogel A, Pelletier J. Examen chimique de la racine de Curcuma. J Pharm 1815; 1: 289-300
    PubMedGoogle Scholar
  • 8 Milobedzka J, Kostanecki V, Lampe V. Structure. Chem Ber 1910; 43: 2163
    PubMedGoogle Scholar
  • 9 Roughley PJ, Whiting DA. Experiments in the biosynthesis of curcumin. J Chem Soc Perkin Trans 1973; 20: 2379-2388
    CrossrefPubMedGoogle Scholar
  • 10 Sharma RA, Gescher AJ, Steward WP. Curcumin: The story so far. Eur J Cancer 2005; 41: 1955-1968
    CrossrefPubMedGoogle Scholar
  • 11 Priyadarsini KI. The chemistry of curcumin: From extraction to therapeutic agent. Molecules 2014; 19: 20091-20112
    CrossrefPubMedGoogle Scholar
  • 12 Kew Science. Plants of the world online: Curcuma longa . Accessed April 21, 2020 at: https://powo.science.kew.org/
    PubMedGoogle Scholar
  • 13 Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008; 65: 1631-1652
    CrossrefPubMedGoogle Scholar
  • 14 Schraufstatter E, Bernt H. Antibacterial action of curcumin and related compounds. Nature 1949; 164: 456
    CrossrefPubMedGoogle Scholar
  • 15 Tyagi P, Singh M, Kumari H, Kumari A, Mukhopadhyay K. Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. PLoS One 2015; 10: 0121313
    CrossrefPubMedGoogle Scholar
  • 16 De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB, Mukhopadhyay AK. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 2009; 53: 1592-1597
    CrossrefPubMedGoogle Scholar
  • 17 Mandroli PS, Bhat K. An in vivo evaluation of antibacterial activity of curcumin against common endodontic bacteria. J App Pharma Sci 2013; 3: 106-108
    PubMedGoogle Scholar
  • 18 Mohammed NA, Habil NY. Evaluation of antimicrobial activity of curcumin against two oral bacteria. Autom Control Intell Syst 2015; 3: 18-21
    PubMedGoogle Scholar
  • 19 Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Topkaya AE. Antibacterial effects of curcumin: An in vitro minimum inhibitory concentration study. Toxicol Ind Health 2016; 32: 246-250
    CrossrefPubMedGoogle Scholar
  • 20 Izui S, Sekine S, Maeda K, Kuboniwa M, Takada A, Amano A, Nagata H. Antibacterial Activity of Curcumin Against Periodontopathic Bacteria. J Peridontol 2016; 87: 83-90
    PubMedGoogle Scholar
  • 21 Bomdyal RS, Shah MU, Doshi YS, Shah VA, Khirade SP. Antibacterial activity of curcumin (turmeric) against periopathogens – An in vitro evaluation. J Ad Clin Res In 2017; 4: 175-180
    PubMedGoogle Scholar
  • 22 Adamczak A, Ozarowski M, Karpinski TM. Curcumin, a natural antimicrobial agent with strain-specific activity. Pharmaceuticals (Basel) 2020; 13: 153
    CrossrefPubMedGoogle Scholar
  • 23 World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. 2017. Accessed February 06, 2020 at: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
    PubMedGoogle Scholar
  • 24 Patridge E, Gareiss P, Kinch MS, Hoyer D. An analysis of FDA-approved drugs: Natural products and their derivatives. Drug Discov Today 2015; 21: 204-207
    CrossrefPubMedGoogle Scholar
  • 25 Savoia D. Plant-derived antimicrobial compounds: Alternatives to antibiotics. Future Microbiol 2012; 7: 979-990
    CrossrefPubMedGoogle Scholar
  • 26 Quave CL. Antibiotics from nature: traditional medicine as a source of new solutions for combating antimicrobial resistance. 2016. Accessed January 05, 2020 at: http://resistancecontrol.info/wp-content/uploads/2016/09/97-102-QUAVE.pdf
    PubMedGoogle Scholar
  • 27 Mathur S, Hoskins C. Drug development: Lessons from nature. Biomed Rep 2017; 6: 612-614
    CrossrefPubMedGoogle Scholar
  • 28 Kim MK, Park JC, Chong Y. Aromatic hydroxyl group plays a critical role in antibacterial activity of the curcumin analogues. Nat Prod Commun 2012; 7: 57-58
    PubMedGoogle Scholar
  • 29 Hamed OA, Mehdawi N, Taha AA, Hamed EM, Al-Nuri MA, Hussein AS. Synthesis and antibacterial activity of novel curcumin derivatives containing heterocyclic moiety. Iran J Pharm Res 2013; 12: 47-56
    PubMedGoogle Scholar
  • 30 Emam DR, Alhajoj AM, Elattar KM, Kheder NA, Fadda AA. Synthesis and evaluation of curcuminoid analogues as antioxidant and antibacterial agents. Molecules 2017; 22: 971
    CrossrefPubMedGoogle Scholar
  • 31 Oglah MH, Mustafa YF. Curcumin analogs: Synthesis and biological activities. Med Chem Res 2020; 29: 479-486
    CrossrefPubMedGoogle Scholar
  • 32 Singh A, Singh JV, Rana A, Bhagat K, Gulati HK, Kumar R, Salwan R, Bhagat K, Kaur G, Singh N, Kumar R, Singh H, Sharma S, Bedi PMS. Monocarbonyl curcumin-based molecular hybrids as potent antibacterial agents. ACS Omega 2019; 4: 11673-11684
    CrossrefPubMedGoogle Scholar
  • 33 Kumar P, Kandi SK, Manohar S, Mukhopadhyay K, Rawat DS. Monocarbonyl curcuminoids with improved stability as antibacterial agents against Staphylococcus aureus and their mechanistic studies. ACS Omega 2019; 4: 675-687
    CrossrefPubMedGoogle Scholar
  • 34 Polaquini CR, Marques BC, Ayusso GM, Morao LG, Sardi JCO, Campos DL, Cavalca LB, Scheffers DJ, Rosalen PL, Pavan FR, Ferreira H, Regasini LO. Antibacterial activity of a new monocarbonyl analog of curcumin MAC 4 is associated with divisome disruption. Bioorg Chem 2021; 109: 104668
    CrossrefPubMedGoogle Scholar
  • 35 Ritmaleni R, Sardjiman AY, Purwantini P. Antimicrobial activity of curcumin analog PGV-6, HGV-6 and GVT-6. Res J Pharm Tech 2021; 14: 599-604
    CrossrefPubMedGoogle Scholar
  • 36 Trotsko N, Kosikowska U, Paneth A, Plech T, Malm A, Wujec A. Synthesis and antibacterial activity of new thiazolidine-2,4-dione-based chlorophenylthiosemicarbazone hybrids. Molecules 2018; 23: 1023
    CrossrefPubMedGoogle Scholar
  • 37 Santos AF, Brotto DF, Favarin LRV, Cabeza NA, Andrade GR, Batistote M, Cavalheiro AA, Neves A, Rodriques DCM, dos Anjos A. Study of the antimicrobial activity of metal complexes and their ligands through bioassays applied to plant extracts. Braz J Pharma 2014; 24: 309-315
    CrossrefPubMedGoogle Scholar
  • 38 Rocha DP, Ferreira G, Ruggiero R, de Oliveira CA, War W, Sources APS, Tavares T, Marzano IM, Pereira-Maia EC. Coordination of metals to antibiotics as a strategy to combat bacterial resistance. Quim Nova 2011; 34: 111-118
    PubMedGoogle Scholar
  • 39 Riswan Ahamed MA, Azarudeen RS, Kani NM. Antimicrobial applications of transition metal complexes of benzothiazole based terpolymer: synthesis, characterization, and effect on bacterial and fungal strains. Bioinorg Chem Appl 2014; 2014: 764085
    CrossrefPubMedGoogle Scholar
  • 40 Tajbakhsh S, Mohammadi K, Deilami I, Zandi K, Fouladvand M, Ramedani E, Asayesh G. Antibacterial activity of indium curcumin and indium diacetylcurcumin. Afr J Biotechnol 2008; 7: 3832-3835
    PubMedGoogle Scholar
  • 41 Hatamie S, Nouri M, Karandikar SK, Kulkarni A, Dhole SD, Phase DM, Kale SN. Complexes of cobalt nanoparticles and polyfunctional curcumin as antimicrobial agents. Mater Sci Eng C 2012; 32: 92-97
    CrossrefPubMedGoogle Scholar
  • 42 Pallikkavil R, Ummathur Muhammed B, Sreedharan S, Krishnankutty K. Synthesis, characterization and antimicrobial studies of Cd(II), Hg(II), Pb(II), Sn(II) and Ca(II) complexes of curcumin. Main Group Met Chem 2013; 36: 123-127
    CrossrefPubMedGoogle Scholar
  • 43 Refat MS. Synthesis and characterization of ligational behaviour of curcumin drug towards some transition metal ions: chelation effect on their thermal stability and biological activity. Spectrochim. Acta A Mol Biomol Spectrosc 2013; 105: 326-337
    CrossrefPubMedGoogle Scholar
  • 44 Liao Y, Yao Y, Yu Y, Zeng Y. Enhanced antibacterial activity of curcumin by combination with metal ions. Colloid Interface Sci Commun 2018; 25: 1-6
    CrossrefPubMedGoogle Scholar
  • 45 Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int 2014; 2014: 186864
    PubMedGoogle Scholar
  • 46 Moghaddam KM, Iranshahi M, Yazdi MC, Shahverdi AR. The combination effect of curcumin with different antibiotics against Staphylococcus aureus . Int J Green Pharm 2009; 3: 141-143
    CrossrefPubMedGoogle Scholar
  • 47 Kali A, Bhuvaneshwar D, Charles PMV, Seetha KS. Antibacterial synergy of curcumin with antibiotics against biofilm producing clinical bacterial isolates. J Basic Clin Pharm 2016; 7: 93-96
    CrossrefPubMedGoogle Scholar
  • 48 Teow SY, Ali SA. Synergistic antibacterial activity of curcumin with antibiotics against Staphylococcus aureus . Pak J Pharm Sci 2015; 28: 2109-2114
    PubMedGoogle Scholar
  • 49 Sukandar EY, Kurniati NF, Puspatriani K, Adityas HP. Antibacterial activity of curcumin in combination with tetracycline against Staphylococcus aureus by disruption of cell wall. Res J Med Plants 2018; 12: 1-8
    CrossrefPubMedGoogle Scholar
  • 50 De Kievit TR, Gillis R, Marx S, Brown C, Iglewski BH. Quorum-sensing genes in Pseudomonas aeruginosa biofilms: Their role and expression patterns. Appl Environ Microbiol 2001; 67: 1865-1873
    CrossrefPubMedGoogle Scholar
  • 51 Morohoshi T, Shiono T, Takidouchi K, Kato M, Kato N, Kato J, Ikeda T. Inhibition of quorum sensing in Serratia marcescens AS-1 by synthetic analogs of N-acylhomoserine lactone. Appl Environ Microbiol 2007; 73: 6339-6344
    CrossrefPubMedGoogle Scholar
  • 52 Liu GY, Nizet V. Color me bad: microbial pigments as virulence factors. Trends Microbiol 2009; 17: 406-413
    CrossrefPubMedGoogle Scholar
  • 53 Packiavathy SV, Priya S, Pandian SK, Ravi AV. Inhibition of biofilm development of uropathogens by curcumin – an anti-quorum sensing agent from Curcuma longa . Food Chem 2014; 148: 453-460
    CrossrefPubMedGoogle Scholar
  • 54 Sharma G, Raturi K, Dang S, Gupta S, Gabrani R. Combinatorial antimicrobial effect of curcumin with selected phytochemicals on Staphylococcus epidermidis . J Asian Nat Prod Res 2014; 16: 535-541
    CrossrefPubMedGoogle Scholar
  • 55 Gordon ON, Luis PB, Sintim HO, Schneider C. Unraveling curcumin degradation: Autoxidation proceeds through spiroepoxide and vinylether intermediates en route to the main bicyclopentadione. J Biol Chem 2015; 290: 4817-4828
    CrossrefPubMedGoogle Scholar
  • 56 Krausz AE, Adler BL, Cabral V, Navati M, Doerner J, Charafeddine RA, Chandra D, Liang H, Gunther L, Clendaniel A, Harper S, Friedman JM, Nosanchuk JD, Friedman AJ. Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent. Nanomedicine 2015; 11: 195-206
    CrossrefPubMedGoogle Scholar
  • 57 Izui S, Sekine S, Maeda K, Kuboniwa M, Takada A, Amano A, Nagata H. Antibacterial activity of curcumin against periodontopathic bacteria. J Periodontol 2016; 87: 83-90
    CrossrefPubMedGoogle Scholar
  • 58 Wu Y, Seyedsayamdost MR. Synergy and target promiscuity drive structural divergence in bacterial alkylquinolone biosynthesis. Cell Chem Biol 2017; 24: 1437
    CrossrefPubMedGoogle Scholar
  • 59 Fulaz S, Vitale S, Quinn L, Casey E. Nanoparticle-biofilm interactions: The role of the EPS matrix. Trends Microbiol 2019; 27: 915-926
    CrossrefPubMedGoogle Scholar
  • 60 Gayani B, Dilhari A, Wijesinghe GK, Kumarage S, Abayaweera G, Samarakoon SR, Perera IC, Kottegoda N, Weerasekera MM. Effect of natural curcumin oidsintercalated layered double hydroxide nanohybrid against Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis: A bactericidal, antibiofilm, and mechanistic study. Microbiologyopen 2019; 8: e00723
    CrossrefPubMedGoogle Scholar
  • 61 Selvam C, Prabu SL, Jordan BC, Purushothaman Y, Umamaheswari A, Hosseini Zare MS, Thilagavathi R. Molecular mechanisms of curcumin and its analogs in colon cancer prevention and treatment. Life Sci 2019; 239: 117032-117043
    CrossrefPubMedGoogle Scholar
  • 62 Zhang C, Zhu X, Li F, Gao F, Tu J, Zhang D. Enhanced eradication of Pseudomonas aeruginosa bio-films by using ultrasound combined with neutrophil and antibiotics. Appl Acoust 2019; 152: 101-109
    CrossrefPubMedGoogle Scholar
  • 63 Yu Q, Deng T, Lin FC, Zhang B, Zink JI. Supramolecular assemblies of heterogeneous mesoporous silica nanoparticles to co-deliver antimicrobial peptides and antibiotics for synergistic eradication of pathogenic biofilms. ACS Nano 2020; 14: 5926-5937
    CrossrefPubMedGoogle Scholar
  • 64 Oda Y. Inhibitory effect of curcumin on SOS functions induced by UV irradiation. Mutat Res 1995; 348: 67-73
    CrossrefPubMedGoogle Scholar
  • 65 Gomez-Gomez JM, Manfredi C, Alonso JC, Blazquez J. A novel role for RecA under non-stress: Promotion of swarming motility in Escherichia coli K-12. BMC Biol 2007; 5: 14-28
    CrossrefPubMedGoogle Scholar
  • 66 Rudrappa T, Bais HP. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. J Agric Food Chem 2008; 56: 1955-1962
    CrossrefPubMedGoogle Scholar
  • 67 Baharoglu Z, Mazel D. SOS, the formidable strategy of bacteria against aggressions. FEMS Microbiol Rev 2014; 38: 1126-1145
    CrossrefPubMedGoogle Scholar
  • 68 Costa SB, Campos ACC, Pereira ACM, de Mattos-Guaraldi AL, Júnior RH, Rosa ACP, Asad LMBO. Adherence to abiotic surface induces SOS response in Escherichia coli K-12 strains under aerobic and anaerobic conditions. Microbiology 2014; 160: 1964-1973
    CrossrefPubMedGoogle Scholar
  • 69 Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Perez-Velez CM, Pagano M, Becerra MC, Cohen T. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 2014; 383: 1572-1579
    CrossrefPubMedGoogle Scholar
  • 70 Strugeon E, Tilloy V, Ploy MC, Da Re S. The stringent response promotes antibiotic resistance dissemination by regulating integron integrase expression in biofilms. MBio 2016; 7: e00868-e00916
    CrossrefPubMedGoogle Scholar
  • 71 Recacha E, Machuca J, Diaz-Diaz S, Garcia-Duque A, Ramos-Guelfo M, Docobo-Perez F, Blazquez J, Pascual A, Rodriguez-Martinez JM. Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinoloneresistant Escherichia coli . J Antimicrob Chemother 2019; 74: 66-73
    PubMedGoogle Scholar
  • 72 van der Heide T, Poolman B. ABC transporters: one, two or four extracytoplasmic substrate-binding sites?. EMBO Rep 2002; 3: 938-943
    CrossrefPubMedGoogle Scholar
  • 73 Jun JH, Seu YB, Lee DG. Candicidal action of resveratrol isolated from grapes on human pathogenic yeast C. albicans . J Microbiol Biotechnol 2007; 17: 1324-1329
    PubMedGoogle Scholar
  • 74 Rai D, Singh JK, Roy N, Panda D. Curcumin inhibits FtsZ assembly: An attractive mechanism for its antibacterial activity. Biochem J 2008; 410: 147-155
    CrossrefPubMedGoogle Scholar
  • 75 Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol Sci 2009; 30: 85-94
    CrossrefPubMedGoogle Scholar
  • 76 Coleman KJ, Ngor E, Reynolds K, Quinn VP, Koebnick C, Young DR, Sternfeld B, Sallis RE. Initial validation of an exercise “vital sign” in electronic medical records. Med Sci Sports Exerc 2012; 44: 2071-2076
    CrossrefPubMedGoogle Scholar
  • 77 Mun SH, Kim SB, Kong R, Choi JG, Kim YC, Shin DW, Kang OH, Kwon DY. Curcumin reverse methicillin resistance in Staphylococcus aureus . Molecules 2014; 19: 18283-18295
    CrossrefPubMedGoogle Scholar
  • 78 Li LM, Li J, Zhang XY. Antimicrobial and molecular interaction studies on derivatives of curcumin against Streptococcus pneumoniae which caused pneumonia. Electron J Biotechnol 2016; 19: 8-14
    CrossrefPubMedGoogle Scholar
  • 79 Barry J, Fritz M, Brender JR, Smith PES, Lee DK, Ramamoorthy A. Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J Am Chem Soc 2009; 131: 4490-4498
    CrossrefPubMedGoogle Scholar
  • 80 Tonon CC, Paschoal MA, Correia M, Spolidorio DMP, Bagnato VS, Giusti JSM, Santos-Pinto L. Comparative effects of photodynamic therapy mediated by curcumin on standard and clinical isolate of Streptococcus mutans . J Contemp Dent Pract 2015; 16: 1-6
    CrossrefPubMedGoogle Scholar
  • 81 Wang H, Hao L, Wang P, Chen M, Jiang S, Jiang S. Release kinetics and antibacterial activity of curcumin loaded zein fibers. Food Hydrocoll 2017; 63: 437-446
    CrossrefPubMedGoogle Scholar
  • 82 Duracka M, Lukac N, Kacaniova M, Kantor A, Hleba L, Ondruska L, Tvrda E. Antibiotics versus natural biomolecules: The case of in vitro induced bacteriospermia by Enterococcus Faecalis in Rabbit Semen. Molecules 2019; 24: 4329-4348
    CrossrefPubMedGoogle Scholar
  • 83 Vemula VR, Lagishetty V, Lingala S. Solubility enhancement techniques. Int J Pharma Sci Rev Res 2010; 5: 41-51
    PubMedGoogle Scholar
  • 84 Tonnesen HH, Masson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 2002; 244: 127-135
    CrossrefPubMedGoogle Scholar
  • 85 Ansari MJ, Ahmed MM, Fatima F, Anwer MK, Jamil S, Al-Shdefat R, Ali BE. Solubility and stability enhancement of curcumin through cyclodextrin complexation. IJBPAS 2014; 3: 266-267
    PubMedGoogle Scholar
  • 86 Ansari MJ, Parveen R. Solubility and stability enhancement of curcumin: Improving drug properties of natural pigment. Drug Dev Ther 2016; 7: 113-116
    CrossrefPubMedGoogle Scholar
  • 87 Hassan AS, El-Mahdy MM, El-Badry M, El-Gindy GEDA. Different approaches for enhancement of curcumin aqueous solubility and dissolution rate. J Adv Biomed Pharm Sci 2019; 2: 152-163
    PubMedGoogle Scholar
  • 88 Celebioglu A, Uyar T. Fast-dissolving antioxidant curcumin/cyclodextrin inclusion complex electrospun nanofibrous webs. Food Chem 2020; 317: 126397
    CrossrefPubMedGoogle Scholar
  • 89 Panda S, Das SK. Inclusion complexation of curcumin with beta cyclodextrin to improve solubility. Der Pharm Lett 2021; 13: 11-18
    PubMedGoogle Scholar
  • 90 Park H, Rho S, Kim Y. Solubility, stability, and bioaccessibility improvement of curcumin encapsulated using 4-α-glucanotransferase-modified rice starch with reversible pH-induced aggregation property. Food Hydrocoll 2019; 95: 19-32
    CrossrefPubMedGoogle Scholar
  • 91 Kannamangalam Vijayan U, Shah NN, Muley AB, Singhal RS. Complexation of curcumin using proteins to enhance aqueous solubility and bioaccessibility: Pea protein vis-à-vis whey protein. J Food Eng 2020; 292: 110258
    CrossrefPubMedGoogle Scholar
  • 92 Wang Y, Lu Z, Wu H, Lv F. Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens. Int J Food Microbiol 2009; 136: 71-74
    CrossrefPubMedGoogle Scholar
  • 93 Taghavi Kevij H, Mohammadian M, Salami M. Complexation of curcumin with whey protein isolate for enhancing its aqueous solubility through a solvent-free pH-driven approach. J Food Process Presev 2019; 43: 14227
    PubMedGoogle Scholar
  • 94 Madhavi BB, Kusum B, Chatanya CK, Madhu MN, Harsha VS, Banji D. Dissolution enhancement of efavirenz by solid dispersion and PEGylation techniques. Int J Pharm Investig 2011; 1: 29-34
    CrossrefPubMedGoogle Scholar
  • 95 Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002; 231: 131-144
    CrossrefPubMedGoogle Scholar
  • 96 da Salva Júnior WF, Pinheiro JGO, de Menezes DLB, Silva NESE, de Almeida PDO, Lima ES, da Veiga Júnior VF, de Azevedo EP, de Lima ÁAN. Development, physicochemical characterization and in vitro anti-inflammatory activity of solid dispersions of α,β amyrin isolated from protium oilresin. Molecules 2017; 22: 1512
    CrossrefPubMedGoogle Scholar
  • 97 Modasiya MK, Patel VM. Studies of solubility of curcumin. Int J Pharm Life Sci 2012; 3: 1490-1497
    PubMedGoogle Scholar
  • 98 Gangurde AB, Kundaikar HS, Javeer SD, Jaiswar DR, Degani MS, Amin PD. Enhanced solubility and dissolution of curcumin by a hydrophilic polymer solid dispersion and its insilico molecular modeling studies. J Drug Deliv Sci Technol 2015; 29: 226-237
    CrossrefPubMedGoogle Scholar
  • 99 Li J, Lee IW, Shin GH, Chen X, Park HJ. Curcumin-Eudragit E PO solid dispersion: A simple and potent method to solve the problems of curcumin. Eur J Pharm Biopharm 2015; 94: 322-332
    CrossrefPubMedGoogle Scholar
  • 100 Alves T, Chaud M, Grotto D, Jozala AF, Pandit R, Rai M, Dos Santos CA. Association of silver nanoparticles and curcumin solid dispersion: Antimicrobial and antioxidant properties. AAPS PharmSciTech 2017; 19: 225-231
    CrossrefPubMedGoogle Scholar
  • 101 Hernandez-Patlan D, Solis-Cruz B, Pontin KP, Latorre JD, Baxter MFA, Hernandez-Velasco X, Merino-Guzman R, Mendez-Albores A, Hargis BM, Lopez-Arellano R, Tellez G. Evaluation of a solid dispersion of curcumin with polyvinylpyrrolidone and boric acid against Salmonella Enteritidis infection and intestinal permeability in broiler chickens: A pilot study. Front Microbiol 2018; 9: 1289
    CrossrefPubMedGoogle Scholar
  • 102 Muthu MJ, Kavitha K, Chitra KS, Nandhineeswari S. Soluble curcumin prepared by solid dispersion using four different carriers: Phase solubility, molecular modelling and physicochemical characterization. Trop J Pharm Res 2019; 18: 1581-1588
    PubMedGoogle Scholar
  • 103 Yu JY, Kim JA, Joung HJ, Ko JA, Park HJ. Preparation and characterization of curcumin solid dispersion using HPMC. J Food Sci 2020; 85: 3866-3873
    CrossrefPubMedGoogle Scholar
  • 104 Shin GH, Li J, Cho JH, Kim JT, Park HJ. Enhancement of curcumin solubility be phase change from crystalline to amorphous in Cur-TPGS nanosuspension. J Food Sci 2016; 81: 494-501
    CrossrefPubMedGoogle Scholar
  • 105 Flora G, Gupta D, Tiwari A. Nanocurcumin: A promising therapeutic advancement over native curcumin. Crit Rev Ther Drug Carrier Syst 2013; 30: 331-368
    CrossrefPubMedGoogle Scholar
  • 106 Elzoghby A, Samy W, Elgindy N. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 2012; 157: 168-182
    CrossrefPubMedGoogle Scholar
  • 107 Bhawana. Basniwal RK, Buttar HS, Jain VK, Jain N. Curcumin nanoparticles: Preparation, characterization, and antimicrobial study. J Agric Food Chem 2011; 59: 2056-2061
    CrossrefPubMedGoogle Scholar
  • 108 Xie M, Fan D, Zhao Z, Li Z, Li G, Chen Y, He X, Chen A, Li J, Lin X, Zhi M, Li Y, Lan P. Nano-curcumin prepared via supercritical: Improved anti-bacterial, anti-oxidant and anti-cancer efficacy. Int J Pharm 2015; 496: 732-740
    CrossrefPubMedGoogle Scholar
  • 109 No DS, Algburi A, Huynh P, Moret A, Ringard M, Comito N, Drider D, Takhistov P, Chikindas ML. Antimicrobial efficacy of curcumin nanoparticles against Listeria monocytogenes is mediated by surface charge. J Food Saf 2017; 37: 12353
    CrossrefPubMedGoogle Scholar
  • 110 Adahoun MA, Al-Akhras MAH, Jaafar MS, Bououdina M. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif Cells Nanomed Biotechnol 2017; 45: 98-107
    CrossrefPubMedGoogle Scholar
  • 111 Jaiswal S, Mishra P. Antimicrobial and antibiofilm activity of curcumin-silver nanoparticles with improved stability and selective toxicity to bacteria over mammalian cells. Med Microbiol Immunol 2018; 207: 39-53
    CrossrefPubMedGoogle Scholar
  • 112 Kumar SSD, Houreld NN, Abrahamse H. Therapeutic potential and recent advances of curcumin in the treatment of aging-associated diseases. Molecules 2018; 23: 835
    CrossrefPubMedGoogle Scholar
  • 113 Prado-Audelo D, María L, Caballero-Florán IH, Meza-Toledo JA, Mendoza-Muñoz N, González-Torres M, Florán B, Cortés H, Leyva-Gómez G. Formulations of curcumin nanoparticles for brain diseases. Biomolecules 2019; 9: 56
    CrossrefPubMedGoogle Scholar
  • 114 Kumari M, Sharma N, Manchanda R, Gupta N, Syed A, Bahkali AH, Nimesh S. PGMD/curcumin nanoparticles for the treatment of breast cancer. Sci Rep 2021; 11: 1-7
    CrossrefPubMedGoogle Scholar
  • 115 Salehi B, Prado-Audelo D, María L, Cortés H, Leyva-Gómez G, Stojanović-Radić Z, Singh YD, Patra JK, Das G, Martins N, Martorell M. Therapeutic applications of curcumin nanomedicine formulations in cardiovascular diseases. J Clin Med 2020; 9: 746
    CrossrefPubMedGoogle Scholar
  • 116 Yavarpour-Bali H, Ghasemi-Kasman M, Pirzadeh M. Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders. Int J Nanomed 2019; 14: 4449
    CrossrefPubMedGoogle Scholar
  • 117 Boarescu PM, Chirilă I, Bulboacă AE, Bocșan IC, Pop RM, Gheban D, Bolboacă SD. Effects of curcumin nanoparticles in isoproterenol-induced myocardial infarction. Oxid Med Cell Longev 2019; 2019: 7847142
    CrossrefPubMedGoogle Scholar
  • 118 Kunwar A, Barik A, Mishra B, Rathinasamy K, Pandey R, Priyadarsini KI. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumour cells. Biochim Biophys Acta 2008; 1780: 673-679
    CrossrefPubMedGoogle Scholar
  • 119 Chang R, Sun L, Webster TJ. Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts. Int J Nanomedicine 2014; 9: 461-465
    PubMedGoogle Scholar
  • 120 Ebrahimifar M, Hasanzadegan Roudsari M, Kazemi SM, Shahmabadi HE, Kanaani L, Alavi SA, Vasfi MI. Enhancing effects of curcumin on cytotoxicity of paclitaxel, methotrexate and vincristine in gastric cancer cells. Asian Pac J Cancer Prev 2017; 18: 65-68
    PubMedGoogle Scholar
  • 121 Li W, Zhou Y, Yang J, Li H, Zhang H, Zheng P. Curcumin induces apoptotic cell death and protective autophagy in human gastric cancer cells. Oncol Rep 2017; 37: 3459-3466
    CrossrefPubMedGoogle Scholar
  • 122 Koohpar ZK, Entezari M, Movafagh A, Hashemi M. Anticancer activity of curcumin on human breast adenocarcinoma: Role of Mcl-1 gene. Iran J Cancer Prev 2015; 8: 2331
    PubMedGoogle Scholar
  • 123 Khan AQ, Siveen KS, Prabhu KS, Kuttikrishnan S, Akhtar S, Shaar A, Raza A, Mraiche F, Dermime S, Uddin S. Curcumin-mediated degradation of s-phase kinase protein 2 induces cytotoxic effects in human papillmavirus-positive and negative squamous carcinoma cells. Front Oncol 2018; 8: 399
    CrossrefPubMedGoogle Scholar
  • 124 Wang C, Song X, Shang M, Zou W, Zhang M, Wei H, Shao H. Curcumin exerts cytotoxicity dependent on reactive oxygen species accumulation in non-small-cell lung cancer cells. Future Oncol 2019; 15: 1243-1253
    CrossrefPubMedGoogle Scholar
  • 125 Walters DK, Muff R, Langsam B, Born W, Fuchs B. Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest New Drugs 2008; 26: 289-297
    CrossrefPubMedGoogle Scholar
  • 126 OʼSullivan-Coyne G, OʼSullivan GC, OʼDonovan TR, Piwocka K, McKenna SL. Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer 2009; 101: 1585-1595
    CrossrefPubMedGoogle Scholar
  • 127 Agrawal S, Goel RK. Curcumin and its protective and therapeutic uses. Nat J Physiol Pharm Pharmacol 2016; 6: 1-8
    CrossrefPubMedGoogle Scholar
  • 128 Dudhatra GB, Mody SK, Awale MM, Patel HB, Modi CM, Kumar A, Kamani DR, Chauhan BN. A comprehensive review on pharmacotherapeutics of herbal bioenhancers. ScientificWorldJournal 2012; 2012: 338-345
    CrossrefPubMedGoogle Scholar
  • 129 Aggarwal ML, Chacko KM, Kuruvilla BT. Investigation of the toxicity of curcuminoid-essential oil complex: A bioavailable turmeric formulation. Mol Med Rep 2016; 13: 592-604
    CrossrefPubMedGoogle Scholar
  • 130 Liju V, Jeena K, Kuttan R. Acute and subchronic toxicity as well as mutagenic evaluation of essential oil from turmeric (Curcuma longa L.). Food Chem Toxicol 2013; 53: 52-61
    CrossrefPubMedGoogle Scholar
  • 131 Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, She TS, Ko JY, Lin JT, Lin BR, Wu MS, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001; 21: 2895-2900
    PubMedGoogle Scholar
  • 132 Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006; 6: 10
    CrossrefPubMedGoogle Scholar
  • 133 Soni KB, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 1992; 36: 273-275
    PubMedGoogle Scholar
  • 134 Cox KH, Pipingas A, Scholey AB. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol 2015; 29: 642-651
    CrossrefPubMedGoogle Scholar
  • 135 Oliver JM, Stoner L, Rowlands DS, Caldwell AR, Sanders E, Kreutzer A, Mitchell JB, Purpura M, Jäger R. Novel form of curcumin improves endothelial function in young, healthy individuals: A double-blind placebo controlled study. J Nutr Metab 2016; 2016: 1089653
    CrossrefPubMedGoogle Scholar
  • 136 Sugawara J, Akazawa N, Miyaki A, Choi Y, Tanabe Y, Imai T, Maeda S. Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study. Am J Hypertens 2012; 25: 651
    CrossrefPubMedGoogle Scholar
  • 137 Fanaei H, Khayat S, Kasaeian A, Javadimehr M. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial. Neuropeptides 2016; 56: 25-31
    CrossrefPubMedGoogle Scholar
  • 138 Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HFK, Goggins WB, Zee BCY, Cheng KF, Fong CYS, Wong A, Mok H, Chow MSS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CYL, Chan MH, Szeto S, Chan HIS, Mok V. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 2008; 28: 110-113
    CrossrefPubMedGoogle Scholar
  • 139 Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM. Oral curcumin for Alzheimerʼs disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 2012; 4: 43
    CrossrefPubMedGoogle Scholar
  • 140 Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, Morrow GR. Curcumin for radiation dermatitis: A randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 2013; 180: 34-43
    CrossrefPubMedGoogle Scholar
  • 141 Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP. Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001; 7: 1894-1900
    PubMedGoogle Scholar
  • 142 Bergman J, Miodownik C, Bersudsky Y, Sokolik S, Lerner PP, Kreinin A, Polakiewicz J, Lerner V. Curcumin as an add-on to antidepressive treatment: A randomized, double-blind, placebo-controlled, pilot clinical study. Clin Neuropharmacol 2013; 36: 73-77
    CrossrefPubMedGoogle Scholar
  • 143 Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD. Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. J Affect Disord 2014; 167: 368-375
    CrossrefPubMedGoogle Scholar
  • 144 Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care 2012; 35: 2121-2127
    CrossrefPubMedGoogle Scholar
  • 145 Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem 2014; 25: 144-150
    CrossrefPubMedGoogle Scholar
  • 146 Kuriakose MA, Ramdas K, Dey B, Iyer S, Rajan G, Elango KK, Suresh A, Ravindran D, Kumar RR, Prathiba R, Ramachandran S, Kumar NA, Thomas G, Somanathan T, Ravindran HK, Ranganathan K, Katakam SB, Parashuram S, Jayaprakash V, Pillai MR. A randomized double-blind placebo-controlled phase IIB trial of curcumin in oral leukoplakia. Cancer Prev Res (Phila) 2016; 9: 683-691
    CrossrefPubMedGoogle Scholar
  • 147 Agarwal KA, Tripathi CD, Agarwal BB, Saluja S. Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: A double-blind, randomized placebo-controlled study. Surg Endosc 2011; 25: 3805-3810
    CrossrefPubMedGoogle Scholar
  • 148 Yang YS, Su YF, Yang HW, Lee YH, Chou JI, Ueng KC. Lipid-lowering effects of curcumin in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial. Phytother Res 2014; 28: 1770-1777
    CrossrefPubMedGoogle Scholar
  • 149 Panahi Y, Ghanei M, Bashiri S, Hajihashemi A, Sahebkar A. Short-term curcuminoid supplementation for chronic pulmonary complications due to sulfur mustard intoxication: Positive results of a randomized double-blind placebo controlled trial. Drug Res (Stuttg) 2015; 65: 567-573
    PubMedGoogle Scholar
  • 150 Nakagawa Y, Mukai S, Yamada S, Matsuoka M, Tarumi E, Hashimoto T, Tamura C, Imaizumi A, Nishihira J, Nakamura T. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: A randomized, double-blind, placebo-controlled prospective study. J Orthop Sci 2014; 19: 933-939
    CrossrefPubMedGoogle Scholar
  • 151 Pinsornsak P, Niempoog S. The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: A randomized control trial. J Med Assoc Thail 2012; 1: 51-58
    PubMedGoogle Scholar
  • 152 Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T, Fujiyama Y, Mitsuyama K, Sata M, Yamada M, Iwaoka Y, Kanke K, Hiraishi H, Hirayama K, Araji H, Yoshii S, Uchijima M, Nagata T, Koide Y. Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006; 4: 1502-1506
    CrossrefPubMedGoogle Scholar
  • 153 Pandaran Sudheeran S, Jacob D, Natinga Mulakal J, Gopinathan Nair G, Maliakel A, Maliakel B, Kuttan R, Im K. Safety, tolerance, and enhanced efficacy of a bioavailable formulation of curcumin with fenugreek dietary fiber on occupational stress: A randomized, double-blind, placebo-controlled pilot study. J Clin Psychopharmacol 2016; 36: 236-243
    CrossrefPubMedGoogle Scholar
  • 154 Hashemzadeh K, Davoudian N, Jaafari MR, Mirfeizi Z. The effect of nanocurcumin in improvement of knee osteoarthritis: A randomized clinical trial. Curr Rheumatol Rev 2020; 16: 158-164
    CrossrefPubMedGoogle Scholar
  • 155 Abbasian S, Soltani-Zangbar MS, Khabbazi A, Farzaneh R, Mahdavi AM, Motavalli R, Hajialilo M, Yousefi M. Nanocurcumin supplementation ameliorates Behcetʼs disease by modulating regulatory T cells: A randomized, double-blind, placebo-controlled trial. Int Immunopharmacol 2021; 101: 108237
    CrossrefPubMedGoogle Scholar
  • 156 Ahmadi R, Salari S, Sharifi MD, Reihani H, Rostamiani MB, Behmadi M, Taherzadeh Z, Eslami S, Rezayat SM, Jaafari MR, Elyasi S. Oral nano-curcumin formulation efficacy in the management of mild to moderate outpatient COVID-19: A randomized triple-blind placebo-controlled clinical trial. Food Sci Nut 2021; 9: 4068-4075
    CrossrefPubMedGoogle Scholar
  • 157 Hosseininasab M, Zarghami M, Mazhari S, Salehifar E, Moosazadeh M, Fariborzifar A, Babaeirad S, Hendouei N. Nanocurcumin as an add-on to antipsychotic drugs for treatment of negative symptoms in patients with chronic schizophrenia: A randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2021; 41: 25-30
    CrossrefPubMedGoogle Scholar